Literature DB >> 18599350

Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.

Hui-Ming Gao1, Jau-Shyong Hong.   

Abstract

Neurodegenerative diseases are a group of chronic, progressive disorders characterized by the gradual loss of neurons in discrete areas of the central nervous system (CNS). The mechanism(s) underlying their progressive nature remains unknown but a timely and well-controlled inflammatory reaction is essential for the integrity and proper function of the CNS. Substantial evidence has documented a common inflammatory mechanism in various neurodegenerative diseases. We hypothesize that in the diseased CNS, interactions between damaged neurons and dysregulated, overactivated microglia create a vicious self-propagating cycle causing uncontrolled, prolonged inflammation that drives the chronic progression of neurodegenerative diseases. We further propose that dynamic modulation of this inflammatory reaction by interrupting the vicious cycle might become a disease-modifying therapeutic strategy for neurodegenerative diseases.

Entities:  

Mesh:

Year:  2008        PMID: 18599350      PMCID: PMC4794280          DOI: 10.1016/j.it.2008.05.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  88 in total

Review 1.  Immunotherapeutic approaches to Alzheimer's disease.

Authors:  Alon Monsonego; Howard L Weiner
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

2.  MAC1 mediates LPS-induced production of superoxide by microglia: the role of pattern recognition receptors in dopaminergic neurotoxicity.

Authors:  Zhong Pei; Hao Pang; Li Qian; Sufen Yang; Tonggauang Wang; Wei Zhang; Xeufei Wu; Shannon Dallas; Belinda Wilson; Jeffrey M Reece; David S Miller; Jau-Shyong Hong; Michelle L Block
Journal:  Glia       Date:  2007-10       Impact factor: 7.452

3.  A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation.

Authors:  A Coxon; P Rieu; F J Barkalow; S Askari; A H Sharpe; U H von Andrian; M A Arnaout; T N Mayadas
Journal:  Immunity       Date:  1996-12       Impact factor: 31.745

4.  Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.

Authors:  Yun Min Ding; Juliann D Jaumotte; Armando P Signore; Michael J Zigmond
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

5.  Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors.

Authors:  Angela M Floden; Shanshan Li; Colin K Combs
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

6.  Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease.

Authors:  Krishnan Sriram; Joanna M Matheson; Stanley A Benkovic; Diane B Miller; Michael I Luster; James P O'Callaghan
Journal:  FASEB J       Date:  2002-07-18       Impact factor: 5.191

7.  Regulation of ciliary neurotrophic factor in cultured rat hippocampal astrocytes.

Authors:  J S Rudge; D Morrissey; R M Lindsay; E M Pasnikowski
Journal:  Eur J Neurosci       Date:  1994-02-01       Impact factor: 3.386

8.  Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein.

Authors:  Wei Zhang; Shannon Dallas; Dan Zhang; Jian-Ping Guo; Hao Pang; Belinda Wilson; David S Miller; Biao Chen; Wanqin Zhang; Patrick L McGeer; Jau-Shyong Hong; Jing Zhang
Journal:  Glia       Date:  2007-08-15       Impact factor: 7.452

9.  Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox.

Authors:  Anna Rubartelli; Michael T Lotze
Journal:  Trends Immunol       Date:  2007-09-12       Impact factor: 16.687

10.  Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide.

Authors:  S D Wright; M T Jong
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  278 in total

1.  Fluoxetine protects neurons against microglial activation-mediated neurotoxicity.

Authors:  Feng Zhang; Hui Zhou; Belinda C Wilson; Jing-Shan Shi; Jau-Shyong Hong; Hui-Ming Gao
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

Review 2.  NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.

Authors:  Hui-Ming Gao; Hui Zhou; Jau-Shyong Hong
Journal:  Trends Pharmacol Sci       Date:  2012-04-11       Impact factor: 14.819

Review 3.  Effects of neuroinflammation on the regenerative capacity of brain stem cells.

Authors:  Isabella Russo; Sergio Barlati; Francesca Bosetti
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

4.  Glycogen synthase kinase-3 negatively regulates anti-inflammatory interleukin-10 for lipopolysaccharide-induced iNOS/NO biosynthesis and RANTES production in microglial cells.

Authors:  Wei-Ching Huang; Yee-Shin Lin; Chi-Yun Wang; Cheng-Chieh Tsai; Hsiang-Chi Tseng; Chia-Ling Chen; Pei-Jung Lu; Po-See Chen; Li Qian; Jau-Shyong Hong; Chiou-Feng Lin
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

5.  A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist.

Authors:  Natasha T Snider; James A Nast; Laura A Tesmer; Paul F Hollenberg
Journal:  Mol Pharmacol       Date:  2009-01-26       Impact factor: 4.436

6.  Exosomes-associated neurodegeneration and progression of Parkinson's disease.

Authors:  Isabella Russo; Luigi Bubacco; Elisa Greggio
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

7.  Diazoxide pretreatment prevents Aβ1-42 induced oxidative stress in cholinergic neurons via alleviating NOX2 expression.

Authors:  Qingxi Fu; Naiyong Gao; Jixu Yu; Guozhao Ma; Yifeng Du; Fumin Wang; Quanping Su; Fengyuan Che
Journal:  Neurochem Res       Date:  2014-04-27       Impact factor: 3.996

8.  Thymoquinone increases the expression of neuroprotective proteins while decreasing the expression of pro-inflammatory cytokines and the gene expression NFκB pathway signaling targets in LPS/IFNγ -activated BV-2 microglia cells.

Authors:  Makini K Cobourne-Duval; Equar Taka; Patricia Mendonca; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2018-05-04       Impact factor: 3.478

9.  REVERSAL OF FIBRONECTIN-INDUCED HIPPOCAMPAL DEGENERATION WITH ENCAPSULATED MESENCHYMAL STROMAL CELLS.

Authors:  Jean-Pierre Dollé; Jeffrey Barminko; Sai Veruva; Casey Moure; Rene Schloss; Martin L Yarmush
Journal:  Nano Life       Date:  2013-12

Review 10.  Traumatic brain injury, neuroinflammation, and post-traumatic headaches.

Authors:  Cynthia L Mayer; Bertrand R Huber; Elaine Peskind
Journal:  Headache       Date:  2013-07-08       Impact factor: 5.887

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.